Device and process for charging of rechargeable batteries of implants

• US 6,227,204 B1
• Filed: 05/14/1999
• Issued: 05/08/2001
• Est. Priority Date: 08/21/1998
• Status: Expired due to Term

• Current Assignee: Cochlear Limited
• Original Assignee: Implex AG Hearing Technology (Cochlear Limited)
• Inventors: Volz, Andreas, Leysieffer, Hans, Baumann, Joachim
• Primary Examiner(s): Lacyk, John P.
• Assistant Examiner(s): SZMAL, BRIAN SCOTT
• Application Number:
  US09/311,566
• Time in Patent Office: 725 Days
• Field of Search: 628/899, 607/33, 607/34, 607/32, 607/29
• US Class Current: 128/899
• CPC Class Codes: H02J 50/12 of the resonant type
• CPC Class Codes: H02J 7/00302 Overcharge protection
• CPC Class Codes: H04R 2225/31 Aspects of the use of accumulators in hearing aids, e.g. rechargeable batteries or fuel cells
• CPC Class Codes: H04R 2225/67 Implantable hearing aids or parts thereof not covered by H04R25/606
• CPC Class Codes: H04R 25/554 using a wireless connection, e.g. between microphone and amplifier or using Tcoils
• CPC Class Codes: H04R 25/606 acting directly on the eardrum, the ossicles or the skull, e.g. mastoid, tooth, maxillary or mandibular bone, or mechanically stimulating the cochlea, e.g. at the oval window

Abstract

A device and a process for charging of rechargeable NiCd, Ni-metal hydride or lithium batteries (12) of implants by transcutaneous transmission of electric power from an external power transmission part (11) to a power receiving part (10) which forms a part of the implant. The charging device is provided with a charging current detector (27, 32, 34) which, in a first charging phase (T1), allows a relatively high charging current (I_L) to flow and which, after the cell voltage (U_Z) of the battery has reached a predetermined limiting charging voltage (U_G), in a second charging phase (T2), reduces the charging current as compared to the charging current which flows at the end of the first charging phase. The charging current detector is made such that, during the second charging phase, it sets the charging current to a value causing the cell voltage during the second charging phase to be kept at least approximately at a predetermined constant voltage value (U_G).

Claims

1. Charging device for charging of rechargeable NiCd, Ni-metal hydride and lithium batteries of implants by transcutaneous transmission of electric power from an external power transmission part to a power receiving part which forms a part of the implant, the charging device comprising a charging current detector having control means for producing a first charging phase in which a relatively high charging current flow is produced which is limited to a stipulated maximum value and for producing a second charging phase in which the charging current is reduced as compared to the charging current which flows in the first charging phase after the cell voltage of a battery being charged has reached a predetermined limiting charging voltage, the reduced charging current in the second charging phase having a value causing the cell voltage to be kept at least approximately to a predetermined constant voltage value during the second charging phase.

2. Charging device as claimed in claim 1, wherein the predetermined constant value at which the cell voltage is kept by said control means during the second charging phase is at least approximately equal to the value of a limiting charging voltage reached at the end of the first charging phase.

3. Charging device as claimed in claim 2, wherein the predetermined constant value at which the cell voltage is kept by said control means during the second charging phase deviates from the limiting charging voltage reached at the end of the first charging phase by not more than ±

30%.

4. Charging device as claimed in claim 3, wherein the predetermined constant value at which the cell voltage is kept by said control means during the second charging phase deviates from the limiting charging voltage reached at the end of the first charging phase by not more than ±

20%.

5. Charging device as claimed in claim 3, wherein the predetermined constant value at which the cell voltage is kept by said control means during the second charging phase deviates from the limiting charging voltage reached at the end of the first charging phase by not more than ±

10%.

6. Charging device as claimed in claim 1, further comprising an arrangement for acquiring the rate of change of the charging current and for ending the charging process when the change of the charging current per unit of time falls below a predetermined minimum value in the course of the second charging phase.

7. Charging device as claimed in claim 1, wherein the charging current detector has means for limiting the charging current during the first charging phase to C/4 to 4C, where C is the nominal capacity of the battery measured in ampere-hours.

8. Charging device as claimed in claim 6, wherein the means for limiting limits the charging current to C/2 to C in the case of Ni-metal hydride battery cells, and C/2 to 2C in the case of lithium battery cells.

9. Charging device as claimed in claim 6, wherein the means for limiting limits the charging current to C/2 to 3/4C in the case of Ni-metal hydride battery cells and C/2 to C in the case of lithium battery cells.

10. Charging device as claimed in claim 1, control means includes an arrangement for incrementally reducing the charging current during the second charging phase.

11. Charging device as claimed in claim 10, wherein the arrangement for incremental reduction of the charging current during the second charging phase has a microcontroller, a voltage controlled resistor which is controlled by the microcontroller, and a digital to analog converter which is connected between the microcontroller and resistor.

12. Charging device as claimed in claim 1, wherein the control means has an arrangement for reducing the charging current during the second charging phase by pulse width modulation of the charging current.

13. Charging device as claimed in claim 1, further comprising an analog to digital converter and a microcontroller for acquiring the cell voltage.

14. Charging device as claimed in claim 1, wherein the external power transmission part is battery-operated.

15. Process for charging of rechargeable NiCd, Ni-metal hydride and lithium batteries of implants by transcutaneous transmission of electric power, comprising the steps of performing a first charging phase in which charging current is limited to a relatively high value, and commencing a second charging phase when the cell voltage of the battery being charged reaches a predetermined limiting charging voltage, the charging current in the second charging phase being reduced as compared to the charging current flowing at the end of the first charging phase, and wherein the charging current in the course of the second charging phase is set to a value which keeps the cell voltage at least roughly to a predetermined constant voltage value.

16. Process as claimed in claim 15, wherein the predetermined voltage value at which the cell voltage is kept in the course of the second charging phase is at least roughly equal to the value of the limiting charging voltage which is reached at the end of the first charging phase.

17. Process as claimed in claim 15, wherein the predetermined voltage value at which the cell voltage is kept during the second charging phase deviates from the limiting charging voltage reached at the end of the first charging phase by not more than ±

30%.

18. Process as claimed in claim 15, wherein the predetermined voltage value at which the cell voltage is kept during the second charging phase deviates from the limiting charging voltage reached at the end of the first charging phase by not more than ±

20%.

19. Process as claimed in claim 15, wherein the predetermined voltage value at which the cell voltage is kept during the second charging phase deviates from the limiting charging voltage reached at the end of the first charging phase by not more than ±

10%.

20. Process as claimed in claim 15, comprising the further steps of acquiring a rate of change of the charging current and ending the charging process when the change of the charging current per unit of time falls below a predetermined minimum value during the second charging phase.

21. Process as claimed in claim 15, wherein the charging current is limited to C/4 to 4C during the first charging phase.

22. Process as claimed in claim 18, wherein the battery is a Ni-metal hydride battery and the charging current is limited a value of C/2 to C during the first charging phase.

23. Process as claimed in claim 18, wherein the battery is a Ni-metal hydride battery and the charging current is limited a value of C/2 to 3/4C during the first charging phase.

24. Process as claimed in claim 18, wherein the battery is a lithium battery and the charging current is limited a value of C/2 to 2C during the first charging phase.

25. Process as claimed in claim 18, wherein the battery is a lithium battery and the charging current is limited a value of from C/2 to C during the first charging phase.

27. Process as claimed in claim 15, wherein the charging current is incrementally reduced during the second charging phase.

28. Process as claimed in claim 15, wherein the charging current is reduced by pulse width modulation during the second charging phase.

29. Process as claimed in claim 15, wherein the transcutaneous transmission of electric power is performed using alternating current with a frequency in the range from 40 kHz to 50 MHz.

30. Process as claimed in claim 15, wherein the transcutaneous transmission of electric power is performed from an external power transmission part to a power receiving part which forms a part of the implant.

26. Process as claimed in 15, wherein the charging current is smoothly reduced during the second charging phase.